Objectives
This systematic review investigated the incidence of stent migration in patients with
acute and chronic deep venous iliofemoral disease who were treated with dedicated
venous stents. Procedural approaches, clinical and stent patency outcomes, and other
complications are described.
Methods
MEDLINE and Embase were searched for literature published from January, 2012 to December,
2021. Evidence on the study population and procedural characteristics, and outcomes
related to symptomatic changes, health-related quality of life, stent patency and
complications was presented.
Results
Fourty-two studies were identified from 857 articles found through the database searches.
Five-hundred seventy acute deep vein thrombosis patients and 2,859 chronic disease
patients were included. Ten dedicated venous stent brands were employed. There were
six episodes of stent migration (0.17% of patients) of which three involved a closed-cell
stent and one involved a hybrid-design stent. The 12-month primary patency rate in
patients with acute deep vein thrombosis ranged from 86 to 88%, whilst secondary patency
was 96%. Amongst the chronic-disease cohort the primary and secondary patency were
noted to range from 59 to 94%, and 87 to 100%, respectively. The pooled 12-month primary
and secondary stent patency rates were 73.8% and 91.5%, respectively.
Conclusions
Iliofemoral stenting using dedicated venous stents is associated with a low rate of
stent migration although this may be due to a lack of reporting. Further research
with specific surveillance protocols is necessary to reliably determine the true incidence
of stent migration.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Annals of Vascular SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
REFERENCES
- The post thrombotic syndrome.Thromb Res. 2011; 127 (S89–92)
- Living with a venous leg ulcer: a descriptive study of patients'experiences.J Adv Nurs. 1995; 22: 1092-1100
- A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications.J Am Acad Dermatol. 1994; 31: 49-53
- Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.Lancet. 2012; 379: 31-38
- Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis.N Engl J Med. 2017; 377: 2240-2252
- Endovascular treatment for venous diseases: where are the venous stents?.Methodist Debakey Cardiovasc J. 2018; 14: 208-213
- A systematic review and meta-analysis of the treatment of obstructive chronic deep venous disease using dedicated venous stents.Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2022; 10: 267-282
U.S. Food & Drug Administration. Boston Scientific Corporation Recalls VICI VENOUS STENT System and VICI RDS VENOUS STENT System for Potential of Stent Migration [Internet]. 2021 [cited 2021 Jul 2]. Available from: https://www.fda.gov/medical-devices/medical-device-recalls/boston-scientific-corporation-recalls-vici-venous-stent-system-and-vici-rds-venous-stent-system.
- Intracardiac venous stent migration: emergency department presentation of a catastrophic complication.J Emerg Med. 2017; 53 (e11–3)
- Acute stent migration into the right ventricle in a patient with iliac vein stenting.Thorac Cardiovasc Surg Reports. 2018; 7 (e7–8)
- Management of misplaced or migrated endovascular stents.J Vasc Interv Radiol. 1999; 10: 851-859
National Institute for Health and Care Excellence (NICE). Healthcare databases advanced search [Internet]. [cited 2020 Sep 14]. Available from: https://hdas.nice.org.uk/.
- Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ).Qual life Res. 1996; 5: 539-554
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.BMJ. 2016; 355 (i4919)
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.BMJ. 2008; 336: 924-926
- Closing the gap between methodologists and end-users: R as a computational back-end.J Stat Softw. 2012; 49: 1-15
- Practical meta-analysis.Thousand Oaks, CA: Sage, 2001
- Cochrane Handbook for Systematic Reviews of Interventions.(editors)2nd ed. John Wiley & Sons, Chichester2019
Rohatgi A. WebPlotDigitizer [Internet]. Pacifica, California, USA; [cited 2020 Sep 7]. Available from: https://automeris.io/WebPlotDigitizer.
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.BMC Med Res Methodol. 2012; 12: 9
- R: A language and environment for statistical computing [Internet].R Foundation for Statistical Computing, Vienna, Austria2020 (Available from)
- Early clinical outcomes of a novel rheolytic directional thrombectomy technique for patients with iliofemoral deep vein thrombosis.Vasa. 2017; 47: 56-62
- The effect of Angiojet rheolytic thrombectomy in the endovascular treatment of lower extremity deep venous thrombosis.Phlebology. 2018; 33: 388-396
- Ultrasound-accelerated catheter-directed thrombolysis in acute iliofemoral deep venous thrombosis.J Vasc surgery Venous Lymphat Disord. 2013; 1: 225-230
- Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: 1-year follow-up data of a randomized-controlled trial.J Thromb Haemost. 2017; 15: 1351-1360
- Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis.Circ Cardiovasc Interv. 2015; 8: e002027
- Fixed low-dose ultrasound-assisted catheter-directed thrombolysis followed by routine stenting of residual stenosis for acute ilio-femoral deep-vein thrombosis.Thromb Haemost. 2014; 111: 1153-1160
- Single-session percutaneous mechanical thrombectomy using the aspirex®s device plus stenting for acute iliofemoral deep vein thrombosis: Safety, efficacy, and mid-term outcomes.Diagnostics (Basel). 2020; 10: 544
- Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial.Lancet Haematol. 2020; 7 (e40–9)
- Iliofemoral venous stenting extending into the femoral region: initial clinical experience with the purpose-designed Zilver Vena stent.J Cardiovasc Surg. 2013; 54: 255-261
- Cessation of anticoagulation therapy following endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis.Vasa. 2019; 48: 331-339
- Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis.Thromb Res. 2018; 172: 86-93
- Venovo venous stent in the treatment of non-thrombotic or post-thrombotic iliac vein lesions – short-term results from the Arnsberg venous registry.Vasa. 2019; 48: 175-180
- Two year outcome after chronic iliac vein occlusion recanalisation using the vici venous stent®.Eur J Vasc Endovasc Surg. 2018; 56: 710-718
- Pivotal study of endovenous stent placement for symptomatic iliofemoral venous obstruction.Circ Cardiovasc Interv. 2019; 12e008268
- Editor's choice – reconstruction of the femoro-ilio-caval outflow by percutaneous and hybrid interventions in symptomatic deep venous obstruction.Eur J Vasc Endovasc Surg. 2017; 54: 495-503
- Endovenous management of chronic venous insufficiency.Angiol e Cir Vasc. 2019; 15: 226-230
- Venoplasty and stenting in post-thrombotic syndrome and non-thrombotic iliac vein lesion.Minim Invasive Ther Allied Technol. 2019; 29: 1-7
- Iliocaval confluence stenting for chronic venous obstructions.Cardiovasc Intervent Radiol. 2015; 38: 1198-1204
- Incidence of stent thrombosis after endovascular treatment of iliofemoral or caval veins in patients with the postthrombotic syndrome.Thromb Haemost. 2019; 119: 2064-2073
- Iliocaval skip stent reconstruction technique for chronic bilateral iliocaval venous occlusion.J Vasc Interv Radiol. 2020; 31: 2060-2065
- Iliac vein pathology and short-term stenting outcomes in a South-East Asian population: A single-centre experience.J Med Imaging Radiat Oncol. 2021; 65: 46-53
- Venovo venous stent for treatment of non-thrombotic or post-thrombotic iliac vein lesions – long-term efficacy and safety results from the Arnsberg venous registry.Vasa. 2020; 50: 1-7
- Endovascular deep vein stenting of symptomatic post-thrombotic and non-thrombotic iliac vein stenotic lesions: a multicentre cohort experience from Singapore.Ann Acad Med Singapore. 2020; 49: 551-560
- Patency rates, safety and clinical results of the sinus-Obliquus venous stent in the treatment of chronic ilio-femoral venous outflow obstruction – data from the Arnsberg venous registry.Vasa. 2019; 48: 270-275
- Braided or laser-cut self-expanding nitinol stents for the common femoral vein in patients with post-thrombotic syndrome.J Vasc surgery Venous Lymphat Disord. 2021; 9: 760-769
- Long term outcome of dedicated venous stents in management of chronic ilio-femoral obstruction.Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2022; 10: 52-59
- Self-expandable nitinol stents for the treatment of nonmalignant deep venous obstruction.Circ Cardiovasc Interv. 2020; 13 (e009673-374)
- Use of the VENOVOTM and Sinus ObliquusTM venous stents in the treatment of non-thrombotic or post-thrombotic iliac vein lesions – Short-term results from a multi-centre Asian cohort.Phlebology. 2021; 36: 70-78
- Comparison of endovascular strategy versus hybrid procedure in treatment of chronic venous obstructions involving the confluence of common femoral vein.Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2022; 10: 334-341
- Twelve-month clinical outcomes of a hybrid oblique self-expanding nitinol stent used for the treatment of post-thrombotic syndrome with common iliac vein compression: The TOPOS study.Vasc Med. 2021; 26: 569-571
- Three-year results from the venovo venous stent study for the treatment of iliac and femoral vein obstruction.Cardiovasc Intervent Radiol. 2021; 44: 1918-1929
- Minimally invasive treatment of chronic iliofemoral venous occlusive disease.J Vasc Surg Venous Lymphat Disord. 2013; 1: 146-153
- Patency rates and clinical outcomes in a cohort of 200 patients treated with a dedicated venous stent.J Vasc Surg Venous Lymphat Disord. 2018; 6: 321-329
- Endovascular treatment of post-thrombotic and non-thrombotic iliofemoral venous outflow obstructions with self-expanding nitinol stents.Vasa. 2018; 47: 319-325
- Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions – short-term safety, patency, and clinical outcomes.Vasa. 2018; 47: 475-481
- The initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstruction.J Vasc Surg Venous Lymphat Disord. 2018; 6: 192-200
- Endovascular stenting for chronic femoro-iliac venous obstructive disease: clinical efficacy and short-term outcomes.Diagn Interv Imaging. 2020; 101: 15-23
- Short-term clinical experience with a dedicated venous nitinol stent: initial results with the sinus-venous stent.Eur J Vasc Endovasc Surg. 2015; 50: 518-526
- Patency and clinical outcomes of a dedicated, self-expanding, hybrid oblique stent used in the treatment of common iliac vein compression.J Endovasc Ther. 2017; 24: 159-166
- Clinical outcomes of venous self-expanding stent placement for iliofemoral venous outflow obstruction.Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2021; 9: 1178-1184
- One-year results of Iliocaval stenting.Ann Vasc Surg. 2019; 59: 208-216
- One year outcomes of the VIVO-EU study of treatment of symptomatic iliofemoral outflow obstruction with the zilver vena venous self-expanding stent.Cardiovasc Intervent Radiol. 2021; 44: 1930-1936
- Short-term clinical experience with a dedicated venous stent.J Vasc Surg Venous Lymphat Disord. 2013; 2: 116
- Reconstruction of the femoro-ilio-caval outflow by percutaneous and hybrid interventions in symptomatic deep venous obstruction.J Vasc Surg. 2017; 66: 1628
- Editor's choice – European society for vascular surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis.Eur J Vasc Endovasc Surg. 2021; 61: 9-82
- Editor's choice – management of chronic venous disease.Eur J Vasc Endovasc Surg. 2015; 49: 678-737
- Avoiding Iliac vein stent migration: techniques and appropriate sizing.Vasc Dis Manag. 2017; 14: E247-E248
- Venous stents: current status and future directions.Tech Vasc Interv Radiol. 2018; 21: 113-116
- The unknowns of venous stenting: why do good cases go bad?.Endovasc Today. 2019; 18: 65-69
- Optimal sizing of iliac vein stents.Phlebology. 2018; 33: 451-457
- Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction.J Vasc surgery Venous Lymphat Disord. 2017; 5: 678-687
- Open surgical removal of iliac vein Wallstents with excision of pseudointima obstructing the contralateral iliac vein.J Vasc Surg Venous Lymphat Disord. 2016; 4: 525-529
- Worsening back and lower leg pain post stenting of the common Iliac vein: is there evidence it is related to stent size?.J Invasive Cardiol. 2020; 32 (E250–3)
- CIRSE standards of practice guidelines on Iliocaval stenting.Cardiovasc Intervent Radiol. 2014; 37: 889-897
- Retrieval of iatrogenic intravascular foreign bodies.J Vasc Surg. 2013; 57: 276-281
- Venous stent migrating to the right heart causing severe regurgitation.J Investig Med High Impact Case Reports. 2020; 8 (2324709620974220)
- Migration of bare-metal stent placed in the right iliac vein into the right pulmonary artery.Ann Thorac Surg. 2020; 110 (e205–7)
- A dual-snare percutaneous retrieval of venous stent embolization to the right heart.JACC Cardiovasc Interv. 2017; 10 (e111–3)
- Reinterventions for nonocclusive iliofemoral venous stent malfunctions.J Vasc Surg. 2009; 49: 511-518
Article Info
Publication History
Published online: January 17, 2022
Accepted:
December 31,
2021
Received in revised form:
December 29,
2021
Received:
November 26,
2021
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
